Conflicts of Interest Disclosure Policy:
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Dr. McLaughlin has disclosed the following financial relationships:
Consultant: Acceleron, Aerovate, Altavant, Bayer, Caremark, Civi Biopharma, Corvista,
Gossamer Bio, Janssen, Merck, United Therapeutics;
Contracted Research: Acceleron, Janssen, Sonovie, United Therapeutics
Accredited Provider Disclosures
Jody Takemoto Ph.D./M.Ed. US HealthConnect / Instructional Designer: has no financial
relationships to disclose.
Dorothy Caputo, MA, BSN, RN, AKH Senior Director of Continuing Education & Compliance: has no financial relationships to disclose.
Bernadette Makar, MSN, APRN-BC, NP-C, Nurse Planner/Reviewer: has no financial relationships to disclose.
Dorothy A. Duffy, RPh - AKH Pharmacy Reviewer: has no financial relationships to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.